Given the importance of intrinsic BCR signaling for survival and progression of CLL as well as support from the tumor microenvironment, research into CLL pathogenesis would benefit from systems that can explore both pathways. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.